Susceptibility of fibromatosis cells in short-term culture to ifosfamide: A possible experimental treatment in clinically aggressive cases

Sarcoma

Volumn 3, Issue 2, 1999, Pages 79-84

  Verrill, Mark W ^a   Coley, Helen M ^b   Judson, Ian R ^b,c   Fisher, Cyril ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Aggressive disease; Chemotherapy; Experimental treatment; Fibromatosis; Ifosfamide

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE; DOXORUBICIN; IFOSFAMIDE; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CELL CULTURE; CELL SURVIVAL; CHEMOSENSITIVITY; DISEASE SEVERITY; ENZYME ANALYSIS; FEMALE; FIBROMATOSIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0032861988     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577149977686     Document Type: Article

References (28)

1. Enzinger FM, Weiss SW. Soft tissue tumours. St Louis: Mosby-Year Book Inc., 1995, pp. 201-229.
2. Hunt RTN, Morgan HC, Ackerman LV. Principles in the management of extraabdominal desmoids. Cancer 1960; 13:825.
3. McKinnon JG, Neifeld JP, Kay S, et al. Management of desmoid tumours. Surg Gynecol Obstet 1989; 169:104.
4. Posner MC, Shiu M, Newsome JL, et al. The desmoid tumour: not a benign disease. Arch Surg 1989; 124:191.
5. Enzinger FM, Shiraki M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): analysis of 30 cases followed up for 10 or more years. Cancer 1967; 21:1131.
6. Kofoed H, Kamby C, Agnostaki L. Aggressive fibromatosis. Surg Gynecol Obstet 1985; 160:124.
7. Brodsky JT, Gordon MS, Hadju SI, et al. Desmoid tumours of the chest wall: a locally recurrent problem. J Thorac Cardiovasc Surg 1992; 104:900.
8. Easter DW, Halasz NA. Recent trends in the management of desmoid tumours: Summary of 19 cases and review of the literature. Ann Surg 1989; 210:765.
9. Markhede G, Lundgren L, Bjurstam N, et al. Extraabdominal desmoid tumours. Acta Orthop Scand 1986; 57:1.
10. Rock MG, Pritchard DJ, Reiman HM, et al. Extraabdominal desmoid tumours. J Bone Jt Surg 1984; 66A:1369.
11. Sherman NE, Romsdahl M, Evans H, et al. Desmoid tumours: a 20 year radiotherapy experience. Int J Radiat Oncol Biol Phys 1990; 19:37.
12. McCullough WM, Parsons JT, van der Griend R, et al. Radiation therapy for aggressive fibromatosis: the experience at the University of Florida. J Bone Jt Surg 1991; 73(A):717.
13. Kiel KD, Suit HD. Radiation therapy in the treatment of aggressive fibromatosis (desmoid tumour). Cancer 1984; 54:2051.
14. Liebel SA, Wara WM, Hill DR, et al. Desmoid tumours: local control and patterns of relapse following radiation therapy. Int J Radial Oncol Biol Phys 1963; 9:1167.
15. Kinzbrunner B, Ritter S, Domingo J, et al. Remission of rapidly growing desmoid tumour after tamoxifen therapy. Cancer 1983; 52:2201.
16. Waddell WR, Gerner RE, Reich MP. Non-steroidal anti-inflammatory drugs and tamoxifen for desmoid tumours and carcinomas of the stomach. J Surg Oncol 1983; 22:197.
17. Wilcken N, Tattersall MH. Endocrine therapy for advanced desmoid tumours. Cancer 1991; 68:1384.
18. Bauernhofer T, Stoger H, Schmid M, et al. Sequential treatment of recurrent mesenteric desmoid tumor. Cancer 1996; 77:1061-5.
19. Lanari A. Effect of progesterone on desmoid tumours (aggressive fibromatosis). New Engl J Med 1983; 309:1523.
20. Weiss AJ, Lackman RD. Low dose chemotherapy of desmoid tumours. Cancer 1989; 64:1192-4.
21. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993; 72:3244-7.
22. Weiss AJ, Lackman RD. Therapy of desmoid tumors, fibromatosis, and related neoplasms. Int J Oncol 1995; 7:773-6.
23. Hamilton L, Blackstein M, Berk T, et al. Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases. Can J Surg 1996; 39:247-52.
24. Coley HM, Lewandowicz G, Sargent J, Verrill MW. Chemosensitivity of Fresh and Continuous Tumour Cell Lines Using Cellular Lactate Dehydrogenase. Anticancer Res 1997; 17:231-6.
25. Coley HM, Verrill MW, Gregson SB, Judson IR. Drug resistance mechanisms in adult soft tissue sarcomas (STS) using primary and established cultures. Proc Annu Meet Am Assoc Cancer Res 1996; 37:311-2.
26. Coley HM, Verrill MW, Judson IR, Fisher C. p53 abnormalities influence modulation of Multi Drug Resistance (MDR) in primary cultures of adult soft tissue sarcoma. Proc Annu Meet Am Assoc Cancer Res 1997; 38:389-90.
27. Lynch HT, Fitzgibbons RJ, Chong S, et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in gardner's syndrome. Dis Colon Rectum 1994; 37:260-7.
28. Raney B, Evans A, Granowetter R, Schnaufer L, Uri A, Littman P. Nonsurgical management of children with recurrent or unresectable fibromatosis. Paediatrics 1987; 79:394-8.